2Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588
4Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741
5The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias[J]. Circulation, 2000, 102(Suppl 8): I 112
6Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. Eur Heart J,2001,22:1 852
8Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation[J]. N Engl J Med, 2002,347:1 825
6Bettencourt P,Januzzi JL Jr.Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure[J].Am J Cardiol,2008,101(3A):67-71.
7Baggish AL,van Kimmenade RR,Januzzi JL Jr.Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea,including those with acute heart failure[J].Am J Cardiol,2008,101(3A):49-51.
8Bettencourt P,Azevedo A,Pimenta J,et al.N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients[J].Circulation,2004,110(15):2168-74.
9Haissaguerre M,Jais P,Shah DC,et al.Spontaneous initidtion ofatrial fibrillation by ectopil beats originating in the pulmonary veins[J].N Engl J Med,1998,339:659-666.
10Wu TJ,Ong JJ,Chang CM,et al.Pulmonary veins and ligament ofmarshall as sources os rapid activations in a canine model of sus-tained atrial fibrillation[J].Circulation,2001,103:1157-1163.
